View in EDS

LBA33 ICON9: International phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy

Saved in:
Bibliographic Details
Title: LBA33 ICON9: International phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy
Authors: Nicum, S.1 (AUTHOR), Ledermann, J.A.2 (AUTHOR), Mileshkin, L.3 (AUTHOR), Jayson, G.C.4 (AUTHOR), Gourley, C.5 (AUTHOR), Michael, A.6 (AUTHOR), Lord, R.7 (AUTHOR), Mackay, H.8 (AUTHOR), Hall, M.9 (AUTHOR), Tookman, L.10 (AUTHOR), Banerjee, S.11 (AUTHOR), Harnett, P.12 (AUTHOR), Macdonald, I.13 (AUTHOR), Lee, Y.C.14 (AUTHOR), Elyashiv, O.13 (AUTHOR), Wilkinson, K.15 (AUTHOR), Farrelly, L.16 (AUTHOR), Counsell, N.17 (AUTHOR)
Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS1225-S1226. 2p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first